( April 16, 2025, 1:31 PM EDT) -- WASHINGTON, D.C. — Patents covering a company’s skin disinfecting product were rightly held by the U.S. Patent Trial and Appeal Board (PTAB) to be unpatentable as anticipated by prior art, a panel in the Federal Circuit U.S. Court of Appeals held April 15; the panel said that substantial evidence supported PTAB’s findings....